Search News
| 37.33 Delayed Data As of Jul 20 |  -0.03 / -0.08%Today’s Change | 32.32 Today|||52-Week Range 39.43 | +3.06% Year-to-Date |
| Previous close | 37.36 |
| Today’s open | 37.20 |
| Day’s range | 37.12 - 37.33 |
| Volume | 14,793,271 |
| Average volume (3 months) | 20,730,695 |
| Market cap | $220.3B |
| Earnings growth (last year) | +200.58% |
| Earnings growth (this year) | +11.28% |
| Earnings growth (next 5 years) | +7.66% |
| Revenue growth (last year) | -0.53% |
| P/E ratio | 10.4 |
| Price/Sales | 4.18 |
| Price/Book | 3.16 |
| Today’s change | Today’s % change | |
|---|---|---|
| NVSNovartis | +1.47 | +1.82% |
| MRKMerck | +0.01 | +0.02% |
| SNYSanofi | +0.44 | +1.05% |
| ABBVAbbVie | -1.04 | -1.16% |
| Next reporting date | July 31, 2018 |
| EPS forecast (this quarter) | $0.74 |
| Annual revenue (last year) | $52.5B |
| Annual profit (last year) | $21.3B |
| Net profit margin | 40.55% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chairman & Chief Executive Officer Ian C. Read |
Chief Operating Officer & Director Albert Bourla |
Corporate headquarters New York, New York |
